154 related articles for article (PubMed ID: 23425820)
1. Stress ulcer prophylaxis in the ICU: who, when, and how?
Bardou M; Barkun AN
Crit Care Med; 2013 Mar; 41(3):906-7. PubMed ID: 23425820
[No Abstract] [Full Text] [Related]
2. Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.
Alhazzani W; Alenezi F; Jaeschke RZ; Moayyedi P; Cook DJ
Crit Care Med; 2013 Mar; 41(3):693-705. PubMed ID: 23318494
[TBL] [Abstract][Full Text] [Related]
3. What's new with stress ulcer prophylaxis in the ICU?
Marker S; Krag M; Møller MH
Intensive Care Med; 2017 Aug; 43(8):1132-1134. PubMed ID: 28238056
[No Abstract] [Full Text] [Related]
4. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol.
Young PJ; Bagshaw SM; Forbes A; Nichol A; Wright SE; Bellomo R; Bailey MJ; Beasley RW; Eastwood GM; Festa M; Gattas D; van Haren F; Litton E; Mouncey PR; Navarra L; Pilcher D; Mackle DM; McArthur CJ; McGuinness SP; Saxena MK; Webb S; Rowan KM;
Crit Care Resusc; 2018 Sep; 20(3):182-189. PubMed ID: 30153780
[TBL] [Abstract][Full Text] [Related]
5. Stress Ulcer Prophylaxis: Who, When, and Why Stress Out About It?
Larson A; Ahrndt S; Jansen T
S D Med; 2016 Apr; 69(4):176-7. PubMed ID: 27263167
[No Abstract] [Full Text] [Related]
6. Cost-Effectiveness of Histamine
Hammond DA; Kathe N; Shah A; Martin BC
Pharmacotherapy; 2017 Jan; 37(1):43-53. PubMed ID: 27809338
[TBL] [Abstract][Full Text] [Related]
7. Stress ulcer prophylaxis: still a valid option in the 1990s?
Schepp W
Digestion; 1993; 54(4):189-99. PubMed ID: 7902305
[No Abstract] [Full Text] [Related]
8. Q: do all hospitalized patients need stress ulcer prophylaxis?
Eisa N; Bazerbachi F; Alraiyes AH; Alraies MC
Cleve Clin J Med; 2014 Jan; 81(1):23-5. PubMed ID: 24391103
[No Abstract] [Full Text] [Related]
9. [Prevention of stress induced ulcers: histamine-2 receptor antagonists or proton pump inhibitors? - gastric hemorrhage occur more often under proton pump inhibitors].
Tank S; Kerner T
Dtsch Med Wochenschr; 2014 Jun; 139(25-26):1338. PubMed ID: 24914510
[No Abstract] [Full Text] [Related]
10. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
11. Stress Ulcer Prophylaxis.
Barletta JF; Bruno JJ; Buckley MS; Cook DJ
Crit Care Med; 2016 Jul; 44(7):1395-405. PubMed ID: 27163192
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
13. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients.
Cook D; Guyatt G
N Engl J Med; 2018 Jun; 378(26):2506-2516. PubMed ID: 29949497
[No Abstract] [Full Text] [Related]
14. [Bleeding and pneumonia in intensive care unit patients given proton pump inhibitor or histamine-2 receptor antagonist for prevention of stress ulcer: a Meta analysis].
Zhou JF; Wan XY; Huang W; Han LL
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2010 Apr; 22(4):221-5. PubMed ID: 20398466
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Prophylaxis of Stress Ulcer in Non-ICU Patients: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials.
Liu Y; Li D; Wen A
Clin Ther; 2020 Mar; 42(3):488-498.e8. PubMed ID: 32046894
[TBL] [Abstract][Full Text] [Related]
16. Famotidine versus pantoprazole.
Lwin AA
Am J Crit Care; 2008 Jul; 17(4):311-2; author reply 312. PubMed ID: 18593828
[No Abstract] [Full Text] [Related]
17. [Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].
Kawai T; Yagi K; Moriyasu F
Nihon Rinsho; 2015 Jul; 73(7):1159-62. PubMed ID: 26165073
[TBL] [Abstract][Full Text] [Related]
18. Stress ulcer prophylaxis: friend or foe?
Macdonald JJ; Roberts JC; Washington S
Br J Hosp Med (Lond); 2012 Apr; 73(4):238. PubMed ID: 22585209
[No Abstract] [Full Text] [Related]
19. Pharmacoepidemiology of stress ulcer prophylaxis in the United States and Canada.
Barletta JF; Kanji S; MacLaren R; Lat I; Erstad BL;
J Crit Care; 2014 Dec; 29(6):955-60. PubMed ID: 25081626
[TBL] [Abstract][Full Text] [Related]
20. [Prophylaxis for stress ulcer bleeding in the intensive care unit].
Avendaño-Reyes JM; Jaramillo-Ramírez H
Rev Gastroenterol Mex; 2014; 79(1):50-5. PubMed ID: 24629722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
